BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35158897)

  • 21. Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study.
    Bailly-Caillé B; Kottler D; Morello R; Lecornu M; Kao W; Meyer E; Dompmartin A; L'Orphelin JM
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma.
    Lavaud J; Blom A; Longvert C; Fort M; Funck-Brentano E; Saiag P
    Eur J Dermatol; 2019 Dec; 29(6):636-640. PubMed ID: 31903954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New and emerging drugs for the treatment of advanced cutaneous squamous cell carcinoma.
    Bonini F; de Sousa LG; Ferrarotto R
    Expert Opin Emerg Drugs; 2023 Dec; 28(2):97-106. PubMed ID: 37144289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Previous radiotherapy increases the efficacy of cemiplimab in the treatment of locally advanced and metastatic cutaneous squamous cell carcinoma: a retrospective analysis.
    Nardone V; Napolitano S; Gagliardi F; Esposito A; Caraglia F; Briatico G; Scharf C; Ronchi A; D'Onofrio I; D'Ippolito E; Russo A; Belfiore MP; Franco R; Argenziano G; Ciardiello F; Reginelli A; Cappabianca S; Troiani T
    J Am Acad Dermatol; 2024 Jun; ():. PubMed ID: 38885840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
    Burton KA; Ashack KA; Khachemoune A
    Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances in the Diagnosis and Management of High-Risk Cutaneous Squamous Cell Carcinoma.
    Dessinioti C; Stratigos AJ
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts.
    Stanganelli I; Spagnolo F; Argenziano G; Ascierto PA; Bassetto F; Bossi P; Donato V; Massi D; Massone C; Patuzzo R; Pellacani G; Quaglino P; Queirolo P; Zalaudek I; Palmieri G; On Behalf Of Italian Melanoma Intergroup Imi
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Cutaneous Squamous Cell Carcinoma of the Scalp: The Role of Imaging and Therapeutic Approaches.
    Verdaguer-Faja J; Toll A; Boada A; Guerra-Amor Á; Ferrándiz-Pulido C; Jaka A
    Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on the anti-programmed cell death-1 receptor antibodies in advanced cutaneous squamous-cell carcinoma.
    Benzaquen M
    Dermatol Ther; 2020 May; 33(3):e13325. PubMed ID: 32208547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation.
    Potestio L; Scalvenzi M; Lallas A; Martora F; Guerriero L; Fornaro L; Marano L; Villani A
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous squamous cell carcinoma: state of the art, perspectives and unmet needs.
    Heppt MV; Leiter U
    J Dtsch Dermatol Ges; 2023 Apr; 21(4):421-424. PubMed ID: 36999577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporation of the 40-Gene Expression Profile (40-GEP) Test to Improve Treatment Decisions in High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients: Case Series and Algorithm.
    Singh G; Tolkachjov SN; Farberg AS
    Clin Cosmet Investig Dermatol; 2023; 16():925-935. PubMed ID: 37051586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Locally advanced and metastatic cutaneous squamous cell carcinoma treated with cemiplimab].
    Vanhakendover L; Lebas E; Libon F; Wauters O; Dezfoulian B; Marchal N; Rorive A; Piret P; Quatresooz P; Jacquemin D; Nikkels AF
    Rev Med Liege; 2019 Jul; 74(7-8):436-440. PubMed ID: 31373461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
    Newlands C; Currie R; Memon A; Whitaker S; Woolford T
    J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment approaches of advanced cutaneous squamous cell carcinoma.
    Peris K; Piccerillo A; Del Regno L; Di Stefani A
    J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():19-22. PubMed ID: 34855254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports.
    Colombo E; Gurizzan C; Ottini A; Caspani F; Bergamini C; Locati LD; Marchiselli C; Alberti A; Lorini L; Licitra LF; Bossi P; Resteghini C
    Front Oncol; 2023; 13():1111146. PubMed ID: 36925925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
    Que SKT; Zwald FO; Schmults CD
    J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; van Akkooi A; Bataille V; Bastholt L; Dreno B; Dummer R; Fargnoli MC; Forsea AM; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Lallas A; Leiter U; Malvehy J; Del Marmol V; Moreno-Ramirez D; Pellacani G; Peris K; Saiag P; Tagliaferri L; Trakatelli M; Ioannides D; Vieira R; Zalaudek I; Arenberger P; Eggermont AMM; Röcken M; Grob JJ; Lorigan P;
    Eur J Cancer; 2023 Nov; 193():113251. PubMed ID: 37717283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cemiplimab and Cutaneous Squamous Cell Carcinoma: From Bench to Bedside.
    Goodman DT
    JPRAS Open; 2022 Sep; 33():155-160. PubMed ID: 36046255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy in the Adjuvant and Advanced Setting of CSCC.
    Muto P; Pastore F
    Dermatol Pract Concept; 2021 Nov; 11(Suppl 2):e2021168S. PubMed ID: 34877076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.